Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01304550
Other study ID # 200917394
Secondary ID 200917394-1
Status Completed
Phase N/A
First received February 23, 2011
Last updated May 24, 2017
Start date July 2009
Est. completion date July 2010

Study information

Verified date May 2017
Source University of California, Davis
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This is a retrospective comparison of hemoglobin measurements obtained by arterial blood gas analysis and the Masimo Continuous Hemoglobin Monitor


Description:

The chief objective of this study is to internally validate the accuracy of the Masimo SpHb (TM) technology as compared to our laboratory measurement of Hb. We have been using the Masimo SpHb monitor on patients who underwent open heart surgery, hepatic resection, kidney transplant and aortic aneurysm repair since January 2009. These patients also had hemoglobin concentration measurements as part of the arterial blood gas analysis performed by our laboratory to evaluate intraoperative ventilation and electrolyte changes. We will collate the laboratory measurements with the Masimo SpHb values documented in the anesthetic records.


Recruitment information / eligibility

Status Completed
Enrollment 48
Est. completion date July 2010
Est. primary completion date July 2010
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

- Patients who had indwelling arterial catheters placed for surgeries that involved major blood loss and who had serial hemoglobin concentration measurements for their surgeries, since January 2009. This will represent approximately 50 patients.

Exclusion Criteria:

- Inclusion criteria are patients undergoing major surgery from January 2009 - April 2009, who had continuous hemoglobin pulse oximetry readings form the Masimo SpHb monitor and serial hemoglobin concentration measurement from the lab. Patient who did not have these studies will be excluded.

Study Design


Related Conditions & MeSH terms

  • Accuracy of Non-invasive Hemoglobin Monitor

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University of California, Davis

Outcome

Type Measure Description Time frame Safety issue
Primary Accuracy of Masimo Monitor 365 Days 1 Year